Search results
15 wrz 2020 · Compared with our prior summary report, 9 overall median survival for patients with brain metastases from all diagnoses has improved in more recent analyses, from 7-12 months—15 months for lung adenocarcinoma—for NSCLC; from 14-16 months for breast cancer; from 7-10 months for melanoma; from 5-8 months for GI cancers; and from 10-12 months ...
- PDF
PURPOSEConventional wisdom has rendered patients with brain...
- Journal of Clinical Oncology
Founded in 1964, the American Society of Clinical Oncology,...
- PDF
9 paź 2024 · Risk varied by cancer types and was lower for prostate (HR 0.80, 95% CI 0.73-0.88), breast (HR 0.91, 95% CI 0.86-0.95), and colorectal (HR 0.90, 95% CI 0.84-0.97) cancer and higher for bladder (HR 1.71, 95% CI 1.54-1.89), brain (HR 1.68, 95% CI 1.42-1.98), and cervical (HR 1.24, 95% CI 1.12-1.38) cancer in PwMS.
11 lip 2023 · Overall, treating brain cancer can be challenging. Depending on a tumor’s location and size, it may be possible to surgically remove a brain tumor completely.
1 sie 2023 · Observational investigations examining cancer risk among multiple sclerosis (MS) patients have produced contradictory findings. Herein, we performed an extensive review and meta-analysis to evaluate the correlation and causation between MS and cancer incidence.
All cancer rates, except breast cancer, cancers located in the nervous system, and lymphomas were reduced in cohort, suggesting that unregulated immune function may provide protective effects to MS patients against cancer. Key Words: Cancer, Multiple Sclerosis, Cohort, Isfahan, Iran.
7 kwi 2021 · Because of improved survival and longer life expectancy, MS patients are more susceptible to cancer diagnosis, and clinicians should be aware of the increased risk of cancer among MS patients above 60 years of age.
13 kwi 2021 · Introduction. Whole-brain radiotherapy (WBRT) has been accepted as a palliative treatment for brain metastasis (BM) 1, based on its ability to control neurologic symptoms and reduce disease...
